Human neutralizing antibodies elicited by SARS-CoV-2 infection

Journal: Nature

Published: 2020-05-26

DOI: 10.1038/s41586-020-2380-z

Affiliations: 12

Authors: 24

Go to article
Institutions Share
National Clinical Research Center for Infectious Diseases at Shenzhen Third People's Hospital, SUSTech, China 0.33
Shenzhen Third People's Hospital, SUSTech, China 0.13
Centre for Global Health and Infectious Diseases, Tsinghua, China 0.10
Comprehensive AIDS Research Center (TUCARC), Tsinghua, China 0.10
MOE Key Laboratory of Protein Sciences, Tsinghua, China 0.08
Beijing Frontier Research Center for Biological Structure, Tsinghua, China 0.08
State Key Laboratory of Respiratory Disease (SKLRD), China 0.04
National Clinical Research Center for Respiratory Disease at The First Affiliated Hospital, GMU, China 0.04
Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, NIFDC, China 0.04
Institutes of Biomedical Sciences (IBS), Fudan University, China 0.02
Shanghai Public Health Clinical Center, Fudan University, China 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER